PLRXPliant Therapeutics, Inc.
1.155USD-1.28%Mkt Cap: 71.52M $P/E: —3d ago
Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap71.52M $
Enterprise Value-60.01M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-149.34M $
Revenue/Share—
Last Price1.155 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees49
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.84
PEG—
EV/EBITDA0.67
EV/Revenue—
P/S—
P/B0.47
EPS (TTM)-1.44
EPS (Forward)-1.33
52W Range
1.02015% of range1.950
52W High1.950 USD
52W Low1.020 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-82.42%
ROA-66.31%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-128.34M $
CapEx (TTM)374.00K $
FCF Margin—
FCF Yield-59.44%
Net Debt-129.36M $
Net Debt/EBITDA1.44
Balance Sheet
Debt/Equity0.16
Current Ratio9.90
Quick Ratio9.64
Book Value/Sh2.373 USD
Cash/Share2.553 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating3.2 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2.500 USD
Upside (mean)+116.5%
Target Range2.000 USD – 3.000 USD
$2.000+116.5% to mean$3.000
# Analysts2
Ownership
Shares Out.61.92M
Float55.03M
Insiders2.23%
Institutions79.24%
Short Interest
Short Ratio4.3d
Short % Float4.64%
Short % Out.4.53%
Shares Short2.81M
Short (prev mo.)2.58M
Technical
SMA 501.110 (+4.0%)
SMA 2001.254 (-7.9%)
Beta1.27
S&P 52W Chg18.16%
Avg Vol (30d)571.08K
Avg Vol (10d)546.83K
Technical Indicators
RSI (14)62.0
MACD0.0026
MACD Signal-0.0130
MACD Hist.+0.0156
BB Upper1.144 USD
BB Middle1.071 USD
BB Lower0.9984 USD
BB Width13.60%
ATR (14)0.0442 USD
Vol Ratio (20d)1.29x